Resultados de búsqueda - Latinis, Kevin

  • Mostrando 1 - 6 Resultados de 6
Limitar resultados
  1. 1
    Stress-Induced Fas Ligand Expression in T Cells Is Mediated through a MEK Kinase 1-Regulated Response Element in the Fas Ligand Promoter

    Stress-Induced Fas Ligand Expression in T Cells Is Mediated through a MEK Kinase 1-Regulated Response Element in the Fas Ligand Promoter por Faris, Mary, Latinis, Kevin M., Kempiak, Stephan J., Koretzky, Gary A., Nel, Andre

    Publicado 1998
    Enlace del recurso Enlace del recurso
    Texto
    Agregar a favoritos
    Guardado en:
  2. 2
    DESCRIPTION OF TWELVE CASES OF NEPHROGENIC FIBROSING DERMOPATHY AND REVIEW OF THE LITERATURE

    DESCRIPTION OF TWELVE CASES OF NEPHROGENIC FIBROSING DERMOPATHY AND REVIEW OF THE LITERATURE por Mendoza, Fabian A., Artlett, Carol M., Sandorfi, Nora, Latinis, Kevin, Piera-Velazquez, Sonsoles, Jimenez, Sergio A.

    Publicado 2006
    Enlace del recurso Enlace del recurso Enlace del recurso
    Texto
    Agregar a favoritos
    Guardado en:
  3. 3
    Differential Requirements for Vav Proteins in DAP10- and ITAM-mediated NK Cell Cytotoxicity

    Differential Requirements for Vav Proteins in DAP10- and ITAM-mediated NK Cell Cytotoxicity por Cella, Marina, Fujikawa, Keiko, Tassi, Ilaria, Kim, Sunjin, Latinis, Kevin, Nishi, Shinzo, Yokoyama, Wayne, Colonna, Marco, Swat, Wojciech

    Publicado 2004
    Enlace del recurso Enlace del recurso Enlace del recurso
    Texto
    Agregar a favoritos
    Guardado en:
  4. 4
    Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus: The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial

    Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus: The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation o... por Merrill, Joan T., Neuwelt, C. Michael, Wallace, Daniel J., Shanahan, Joseph C., Latinis, Kevin M., Oates, James C., Utset, Tammy O., Gordon, Caroline, Isenberg, David A., Hsieh, Hsin-Ju, Zhang, David, Brunetta, Paul G.

    Publicado 2010
    Enlace del recurso Enlace del recurso Enlace del recurso
    Texto
    Agregar a favoritos
    Guardado en:
  5. 5
    Blockade of Interferon‐γ Normalizes Interferon‐Regulated Gene Expression and Serum CXCL10 Levels in Patients With Systemic Lupus Erythematosus

    Blockade of Interferon‐γ Normalizes Interferon‐Regulated Gene Expression and Serum CXCL10 Levels in Patients With Systemic Lupus Erythematosus por Welcher, Andrew A., Boedigheimer, Michael, Kivitz, Alan J., Amoura, Zahir, Buyon, Jill, Rudinskaya, Alla, Latinis, Kevin, Chiu, Kit, Oliner, Kelly S., Damore, Michael A., Arnold, Gregory E., Sohn, Winnie, Chirmule, Narendra, Goyal, Lovely, Banfield, Christopher, Chung, James B.

    Publicado 2015
    Enlace del recurso Enlace del recurso Enlace del recurso
    Texto
    Agregar a favoritos
    Guardado en:
  6. 6
    Belimumab Reduces Autoantibodies, Normalizes Low Complement, and Reduces Select B-Cell Populations in Patients With Systemic Lupus Erythematosus

    Belimumab Reduces Autoantibodies, Normalizes Low Complement, and Reduces Select B-Cell Populations in Patients With Systemic Lupus Erythematosus por STOHL, WILLIAM, HIEPE, FALK, LATINIS, KEVIN M., THOMAS, MATHEW, SCHEINBERG, MORTON A., CLARKE, ANN, ARANOW, CYNTHIA, WELLBORNE, FRANK R., ABUD-MENDOZA, CARLOS, HOUGH, DOUGLAS R., PINEDA, LILIA, MIGONE, THI-SAU, ZHONG, Z. JOHN, FREIMUTH, WILLIAM W., CHATHAM, W. WINN

    Publicado 2012
    Enlace del recurso Enlace del recurso Enlace del recurso
    Texto
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: